ArticleCancers2022

Use of Selective Serotonin Reuptake Inhibitors Is Associated with a Lower Risk of Colorectal Cancer among People with Family History.

Naiqi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.